Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PDE3B antagonists(phosphodiesterase 3B antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | KR | - |